XENDIOR Trademark

Trademark Overview

On Friday, January 2, 2015, a trademark application was filed for XENDIOR with the United States Patent and Trademark Office. The USPTO has given the XENDIOR trademark a serial number of 86494105. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 21, 2019. This trademark is owned by Pfizer Inc.. The XENDIOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
xendior

General Information

Serial Number86494105
Word MarkXENDIOR
Filing DateFriday, January 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 13, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 11435

Trademark Events

Event DateEvent Description
Tuesday, January 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018EXTENSION 5 GRANTED
Tuesday, May 8, 2018EXTENSION 5 FILED
Tuesday, May 8, 2018TEAS EXTENSION RECEIVED
Saturday, November 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2017EXTENSION 4 GRANTED
Thursday, November 2, 2017EXTENSION 4 FILED
Thursday, November 2, 2017TEAS EXTENSION RECEIVED
Friday, June 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2017EXTENSION 3 GRANTED
Wednesday, June 7, 2017EXTENSION 3 FILED
Wednesday, June 7, 2017TEAS EXTENSION RECEIVED
Tuesday, November 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 12, 2016EXTENSION 2 GRANTED
Tuesday, October 25, 2016EXTENSION 2 FILED
Thursday, November 10, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 25, 2016TEAS EXTENSION RECEIVED
Friday, June 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2016EXTENSION 1 GRANTED
Wednesday, June 1, 2016EXTENSION 1 FILED
Wednesday, June 1, 2016TEAS EXTENSION RECEIVED
Tuesday, December 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 14, 2015ASSIGNED TO LIE
Wednesday, August 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 6, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 6, 2015NON-FINAL ACTION E-MAILED
Friday, March 6, 2015NON-FINAL ACTION WRITTEN
Friday, March 6, 2015ASSIGNED TO EXAMINER
Tuesday, January 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 6, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

xendior preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases